The results of qRT-PCR and western blotting showed that supernatant from siCtrl-transfected GBM cells could promote the expression of CD133, SOX2, OCT4, and NANOG, compared to siHMGB1-transfected GBM cells (Figures 4A,B). The gene discussed is PROM1; the disease is glioblastoma.